M23-324 PH 1 Dose Escalation-Expansion
ClinicalTrials.gov NCT05618028
Research payments
$9,938
Through program year 2024, $9,938 in research payments was reported against M23-324 PH 1 Dose Escalation-Expansion, across 9 payments, paid by AbbVie, Inc..
- Paid by
- AbbVie, Inc.
- ClinicalTrials.gov
- NCT05618028
By program year
1 row| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2024 | Research | $9,938 | 9 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
9 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Jan Burger Houston, TX Named on 1 payment
- Nakhle Saba Baton Rouge, LA Named on 1 payment
- Andrew Sochacki Grand Rapids, MI Named on 1 payment
- Ryan Jacobs Charlotte, NC Named on 1 payment
- Jacqueline Barrientos Miami Beach, FL Named on 1 payment
- Herbert Eradat Los Angeles, CA Named on 1 payment
- Sunil Babu Fort Wayne, IN Named on 1 payment
- Meghan Thompson New York, NY Named on 1 payment
- Jorge Chaves Tacoma, WA Named on 1 payment
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.